Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 258

1.

Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.

Glinskii AB, Ma S, Ma J, Grant D, Lim CU, Guest I, Sell S, Buttyan R, Glinsky GV.

Cell Cycle. 2011 Oct 15;10(20):3571-97. doi: 10.4161/cc.10.20.17842.

PMID:
22067658
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders.

Glinskii AB, Ma J, Ma S, Grant D, Lim CU, Sell S, Glinsky GV.

Cell Cycle. 2009 Dec;8(23):3925-42. Epub 2009 Dec 17.

PMID:
19923886
[PubMed - indexed for MEDLINE]
Free Article
3.

The riddle of intergenic disease-associated loci.

Manolio TA, Chanock SJ.

Cell Cycle. 2012 Jan 1;11(1):15-6. doi: 10.4161/cc.11.1.18731. Epub 2012 Jan 1. No abstract available.

PMID:
22193034
[PubMed - indexed for MEDLINE]
Free Article
4.

Bridging the gaps: from risk loci via non-coding RNAs to gene networks and prostate cancer phenotypes.

Mills IG.

Cell Cycle. 2011 Dec 15;10(24):4204. doi: 10.4161/cc.10.24.18411. Epub 2011 Dec 15. No abstract available.

PMID:
22127204
[PubMed - indexed for MEDLINE]
Free Article
5.

Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes.

Glinsky GV.

Cell Cycle. 2008 Dec;7(23):3680-94. Epub 2008 Dec 6.

PMID:
19029827
[PubMed - indexed for MEDLINE]
Free Article
6.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
[PubMed - indexed for MEDLINE]
Free Article
7.

A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.

Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BA.

PLoS Genet. 2011 Jul;7(7):e1002165. doi: 10.1371/journal.pgen.1002165. Epub 2011 Jul 21.

PMID:
21814516
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.

Pal P, Xi H, Guha S, Sun G, Helfand BT, Meeks JJ, Suarez BK, Catalona WJ, Deka R.

Prostate. 2009 Oct 1;69(14):1548-56. doi: 10.1002/pros.20999.

PMID:
19562729
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.

Wasserman NF, Aneas I, Nobrega MA.

Genome Res. 2010 Sep;20(9):1191-7. doi: 10.1101/gr.105361.110. Epub 2010 Jul 13.

PMID:
20627891
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.

Chung S, Nakagawa H, Uemura M, Piao L, Ashikawa K, Hosono N, Takata R, Akamatsu S, Kawaguchi T, Morizono T, Tsunoda T, Daigo Y, Matsuda K, Kamatani N, Nakamura Y, Kubo M.

Cancer Sci. 2011 Jan;102(1):245-52. doi: 10.1111/j.1349-7006.2010.01737.x. Epub 2010 Sep 28.

PMID:
20874843
[PubMed - indexed for MEDLINE]
12.

Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.

Terada N, Tsuchiya N, Ma Z, Shimizu Y, Kobayashi T, Nakamura E, Kamoto T, Habuchi T, Ogawa O.

Prostate. 2008 Nov 1;68(15):1689-95. doi: 10.1002/pros.20831.

PMID:
18726982
[PubMed - indexed for MEDLINE]
13.

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.

Porkka KP, Tammela TL, Vessella RL, Visakorpi T.

Genes Chromosomes Cancer. 2004 Jan;39(1):1-10.

PMID:
14603436
[PubMed - indexed for MEDLINE]
14.

Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.

Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D.

Oncogene. 2003 Feb 27;22(8):1261-72.

PMID:
12606954
[PubMed - indexed for MEDLINE]
15.

Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.

Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, Park JK, Fadda P, Tili E, Nakanishi H, Huh MI, Kim SH, Cho JH, Sung BH, Peng Y, Lee TJ, Luo Z, Sun HL, Wei H, Alder H, Oh JS, Shim KS, Ko SB, Croce CM.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4173-8. doi: 10.1073/pnas.1400350111. Epub 2014 Mar 4.

PMID:
24594601
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.

Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G.

Nat Genet. 2007 May;39(5):645-9. Epub 2007 Apr 1.

PMID:
17401363
[PubMed - indexed for MEDLINE]
17.

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.

Schulz WA, Alexa A, Jung V, Hader C, Hoffmann MJ, Yamanaka M, Fritzsche S, Wlazlinski A, M├╝ller M, Lengauer T, Engers R, Florl AR, Wullich B, Rahnenf├╝hrer J.

Mol Cancer. 2007 Feb 5;6:14.

PMID:
17280610
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Protocadherin-PC promotes androgen-independent prostate cancer cell growth.

Terry S, Queires L, Gil-Diez-de-Medina S, Chen MW, de la Taille A, Allory Y, Tran PL, Abbou CC, Buttyan R, Vacherot F.

Prostate. 2006 Jul 1;66(10):1100-13.

PMID:
16637074
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW.

PLoS One. 2009 Dec 21;4(12):e8384. doi: 10.1371/journal.pone.0008384.

PMID:
20027305
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.

PMID:
16963837
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk